Who Paid My Doc
1Lm SCLC Tecentriq Lurbinectedin
Research payments
$2,219,453
Through program year 2025, $2,219,453 in research payments was reported against 1Lm SCLC Tecentriq Lurbinectedin, across 353 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $373,740 | 75 |
| 2024 | Research | $549,910 | 73 |
| 2023 | Research | $660,250 | 114 |
| 2022 | Research | $632,419 | 89 |
| 2021 | Research | $3,135 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Greg Gerstner Peoria, IL Named on 63 payments
- Yuanbin Chen Grand Rapids, MI Named on 23 payments
- Hossein Borghaei King Of Prussia, PA Named on 15 payments
- Davey Daniel Chattanooga, TN Named on 13 payments
- Steven McCune Marietta, GA Named on 12 payments
- Melissa Johnson Nashville, TN Named on 12 payments
- Jessica Hellyer Spokane Valley, WA Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.